Navigation Links
IDEXX Laboratories Elects Joseph Vumbacco as Director
Date:3/2/2010

WESTBROOK, Maine, March 2 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX), announced today that Mr. Joseph V. Vumbacco has been elected to its Board of Directors. Mr. Vumbacco served as Chief Executive Officer of Health Management Associates, Inc. (HMA), a premier operator of acute care hospitals, from 2001 until June 2007, and as Vice Chairman of HMA from June 2007 until his retirement in December 2007.  Before joining HMA, Mr. Vumbacco had a nearly 15-year career with The Turner Corporation, a publicly-traded construction and real estate company, where he served most recently as Executive Vice President. Mr. Vumbacco also served as Senior Vice President and General Counsel at The F&M Schaefer Corporation, a publicly-traded brewing company, and earlier as an attorney at the Wall Street firm of Mudge Rose Guthrie & Alexander where he specialized in corporate and securities law.

"We are very fortunate to have Joseph Vumbacco join our Board of Directors," said Jonathan W. Ayers, Chairman and Chief Executive Officer of IDEXX Laboratories. "Joe brings a wealth of executive leadership experience to our Board, including experience managing HMA during a period of significant and sustained revenue growth. I believe that Joe's experience as a chief executive, as well as his experience in other executive leadership positions, will be a valuable addition to our Board."

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,800 people and offers products to customers in over 100 countries.

Contact: Merilee Raines, Chief Financial Officer, 1-207-556-8155

SOURCE IDEXX Laboratories, Inc.

Back to top

RELATED LINKS
http://www.idexx.com

'/>"/>

SOURCE IDEXX Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. IDEXX Laboratories Announces Second Quarter Results
2. IDEXX Laboratories to Release 2009 Second Quarter Financial Results
3. IDEXX Laboratories to Present at William Blair 29th Annual Growth Stock Conference
4. IDEXX Laboratories Announces First Quarter Results
5. IDEXX Laboratories to Release 2009 First Quarter Financial Results
6. IDEXX Laboratories Announces Fourth Quarter and Full Year Results
7. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
8. IDEXX Laboratories Names William Brown Corporate Vice President
9. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
10. IDEXX Laboratories to Release 2008 First Quarter Financial Results
11. IDEXX Laboratories Announces Increase in Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of ... American businesses. , The increasingly modern world of instantaneous consumption proves very convenient ... energy sources such as oil and coal, which pollutes our air, water, and soil. ...
(Date:2/13/2016)... ... ... In the early or “honeymoon” stage of a relationship, couples strive to ... way to be romantic, and may exaggerate a strength or two in an effort ... , A recent study from Queendom.com , however, suggests that new couples ...
(Date:2/12/2016)... Opelousas, LA (PRWEB) , ... February 12, 2016 , ... ... of St. Landry and Evangeline Parishes. The purpose of these scholarships is to ... to encourage those individuals to seek employment within these two parishes. , “We ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... life cycle of pharmaceutical products, garnering increased attention from all stakeholders in the ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... nominations have closed for the ISE Southeast Awards 2016. Finalists and winners of ... the ISE® Southeast Executive Forum and Awards Gala on March 15, 2016 at ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... VIEJO , Kalifornien, 12. Februar 2016 /PRNewswire/ ... mit der Aufnahme von Patienten für eine Studie ... von Aneurysmen („WEB") speziell für die Behandlung von ... Spelle , MD, Leiter der Neuroradiologie an der ... Frankreich, und Hauptprüfarzt der CLARYS-Studie hat den ersten ...
(Date:2/12/2016)... ALISO VIEJO, Calif. , Feb. 12, 2016 /PRNewswire/ ... patient enrollment in a study to evaluate the safety ... specifically for the treatment of ruptured intracranial aneurysms.  Prof ... Bicetre University Hospital, in Paris, France ... the first patient. France ...
(Date:2/12/2016)... and SEOUL, South Korea ... Biosys­tems Menarini and Macrogen, Inc. today announced they ... and innovative procedures for precision medicine in cancer. ... Silicon Biosystems, DEPArray™ digital-sorting technology with Macrogen,s high-throughput ... tests certified under the Clinical Laboratory Improvement Amendments ...
Breaking Medicine Technology: